🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

307 results for “Disc Medicine” Clear

  1. -

    Disc Medicine

    Resectable colorectal rectal metastases without extrahepatic disease

    phase 3 small molecule active

    1 trial

  2. 89Zr-CED88004S

    Disc Medicine

    Large B-cell lymphoma

    phase 3 small molecule active

    1 trial

  3. A national randomised multi-centre phase II/III trial using MesoPher in ABC borderline resectable pancreatic cancer (PREOPANC-6 trial)

    Disc Medicine

    ABC borderline resectable pancreatic cancer

    phase 3 other active

    1 trial

  4. ATOMOXETINE , PAROXETINE , MIANSERIN , VORTIOXETINE , VENLAFAXINE , DESVENLAFAXINE , KETAMINE , CLOMIPRAMINE , DULOXETINE , DOSULEPIN , IMIPRAMINE , AMITRIPTYLINE , ESCITALOPRAM , NORTRIPTYLINE , MILNACIPRAN , SERTRALINE , ESKETAMINE , FLUVOXAMINE , REBOXETINE , FLUOXETINE , TRAZODONE , CITALOPRAM , BUPROPION , AGOMELATINE , MIRTAZAPINE , ESKETAMINE , TIANEPTINE

    Disc Medicine

    Major depressive disorder

    phase 3 small molecule active

    1 trial

  5. AchilleS tendinoPathy treated with cortIcosteRoid injEctions.

    Disc Medicine

    Achilles tendinopathy

    phase 3 other active

    1 trial

  6. Atomoxetine Aurobindo 40 mg hard capsules, Microcrystalline cellulose gelatin capsule

    Disc Medicine

    Parkinson's disease

    phase 3 small molecule active

    1 trial

  7. Bitopertin

    Disc Medicine

    X-Linked Protoporphyria (XLP), Erythropoietic Protoporphyria (EPP)

    phase 3 small molecule active

    1 trial

  8. Bitopertin, Matching Placebo

    Disc Medicine

    X-Linked Protoporphyria (XLP), Erythropoietic Protoporphyria (EPP)

    phase 3 small molecule active

    1 trial

  9. CAPECITABINE

    Disc Medicine

    Salivary Duct Carcinoma

    phase 3 small molecule active

    1 trial

  10. CETUXIMAB

    Disc Medicine

    oral squamous cell carcinoma

    phase 3 small molecule active

    1 trial

  11. Concurrent chemotherapy

    Disc Medicine

    Uterine Cervical Neoplasms

    phase 3 small molecule active

    1 trial

  12. DAPAGLIFLOZIN, PLACEBO

    Disc Medicine

    Hypomagnesemia due to HNF1beta mutation

    phase 3 small molecule active

    1 trial

  13. DAPAGLIFLOZIN, Placebo for dapagliflozin film-coated tablets 10 mg

    Disc Medicine

    Combined endpoint of all-cause mortality, kidney failure, and hospitalization for heart failure in the overall study population

    phase 3 small molecule active

    1 trial

  14. DISC-1459

    Disc Medicine

    Erythropoietic Protoporphyria

    phase 3 small molecule active

    2 trials

  15. ETIDRONATE DISODIUM ORAL CAPSULES 400 MG

    Disc Medicine

    Pseudoxanthoma Elasticum

    phase 3 small molecule active

    1 trial

  16. Eligard 22,5 mg poeder en oplosmiddel voor oplossing voor injectie

    Disc Medicine

    Patients with biochemical recurrence after primary treatment of prostate cancer presenting with =<4 metastases

    phase 3 small molecule active

    1 trial

  17. Erleada 240 mg film-coated tablets, Erleada 60 mg film-coated tablets, Docetaxel AqVida 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung

    Disc Medicine

    Metastatic hormone-sensitive prostate cancer

    phase 3 small molecule active

    1 trial

  18. FET

    Disc Medicine

    ACTH-dependent hypercortisolism

    phase 3 small molecule active

    1 trial

  19. FLUOROURACIL , CAPECITABINE , Folikabi 10 mg/ml oplossing voor injectie/infusie, OXALIPLATIN

    Disc Medicine

    Rectal cancer

    phase 3 small molecule active

    1 trial

  20. GALLIUM (68GA) CHLORIDE, TILMANOCEPT

    Disc Medicine

    Endometrial cancer, uterine cancer

    phase 3 small molecule active

    1 trial

  21. GALLIUM (68GA) CHLORIDE, TILMANOCEPT

    Disc Medicine

    Carcinoma of the parotid gland

    phase 3 small molecule active

    1 trial

  22. GALLIUM (68GA) GOZETOTIDE , Zr-DFO-girentuximab, Gallium (68Ga) PSMA-11 (gozetotide) prepared using PSMA-11 Sterile Cold Kit

    Disc Medicine

    Metastatic renal cell carcinoma

    phase 3 small molecule active

    1 trial

  23. Glucose 5% 50 ml

    Disc Medicine

    Apnea of prematurity

    phase 3 small molecule active

    1 trial

  24. HEPARIN , NADROPARIN

    Disc Medicine

    All patients who receive ECMO treatment during the study period in one the participating centers from which (deferred) informed consent is obtained. Patients in whom the ECMO is only used to bridge a procedure like a high risk percutaneous coronary intervention or during surgery are excluded.

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources